Head-To-Head Contrast: AdaptHealth (NASDAQ:AHCO) & Valeritas (OTCMKTS:VLRXQ)

AdaptHealth (NASDAQ:AHCO) and Valeritas (OTCMKTS:VLRXQ) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Analyst Ratings

This is a breakdown of current ratings and target prices for AdaptHealth and Valeritas, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	2	0	5	0	2.43
Valeritas	0	0	0	0	0.00

AdaptHealth presently has a consensus target price of $13.60, indicating a potential upside of 49.29%. Given AdaptHealth’s stronger consensus rating and higher possible upside, equities research analysts clearly believe AdaptHealth is more favorable than Valeritas.

Profitability

This table compares AdaptHealth and Valeritas’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AdaptHealth	2.53%	4.85%	1.75%
Valeritas	N/A	N/A	N/A

Valuation & Earnings

This table compares AdaptHealth and Valeritas”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.26 billion	0.38	$90.42 million	$0.55	16.56
Valeritas	N/A	N/A	N/A	N/A	N/A

AdaptHealth has higher revenue and earnings than Valeritas.

Insider & Institutional Ownership

82.7% of AdaptHealth shares are owned by institutional investors. 1.6% of AdaptHealth shares are owned by insiders. Comparatively, 1.0% of Valeritas shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

AdaptHealth beats Valeritas on 9 of the 9 factors compared between the two stocks.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

About Valeritas

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.